Press release
Nano Med Tech Hires Stateside Sales Team
Nano Med Tech, a newly emerging leader in nano-technological cancer research and treatment, announced that its sales team for America is in place and that stateside medical marketing will commence, soon.With a Commercial Director and eight account managers in place,
Nano Med Tech will now seek to make its technology available in
medical institutions throughout the United States. The organization has received USFDA approval for several patented medical devices, which utilize advanced nanoparticles for the treatment of malignant tumors.
Phillip Skellar joins the company as US Sales Director and will head the company’s commercialization efforts. Mr. Skellar has over 25 years of experience in the pharmaceutical industry, including extensive experience
in the area of oncology. His professional experience includes a leading
position held at Eli Lilly.
"I am extremely pleased to welcome Phil Skellar and his team of account managers to Nano Med Tech. The implementation of commercializing the fruits of our research is a major milestone in transitioning Nano Med Tech from a research organization into a commercially operating entity," said William Hung, spokesman for the company.
Nano Med Tech is a biomedical research organization with its primary facility in Shanghai, China. The organization focuses on human application of nano-technology, particularly in the field of cancer treatment. To view the new Nano Med Tech website, visit www.nanomedtech-china.com.
Nano Med Tech,
1001 Tian Lin Road
Caohejin Hi-Tech Park,
Shanghai,
China 200233
admin@nanomedtech-china.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nano Med Tech Hires Stateside Sales Team here
News-ID: 207374 • Views: …
More Releases from Nano Med Tech
Nano Med Tech Researchers Develop Application to Improve Antibiotics
Nano Med Tech researchers are developing multi-chambered nanoparticles that are attracted to infected cells but harmless to healthy tissues. When integrated into antibiotics, they will make the drugs much more effective by ensuring that they reach only those cells in need of treatment. As the particles have been specifically engineered to penetrate through the bacterial cell membranes, researchers are confident that these new drugs should be far more effective…
Newly Engineered “Mimic” Nanoparticles to Aid Cancer Treatment Say Researche …
Nanoparticles “impersonating” red blood cells will be able to fool the immune system and deliver their payload of cancer-disolving drugs directly to a tumor, say researchers at Shanghai’s Nano Med Tech.
The researchers, led by Dr. Xiao Yan Fat, say that they have developed a method that of taking the membrane off of a red blood cell and wrapping it like a disguise around a biodegradable nanoparticle packing with a specific…
Molded and Reshaped Nanoparticles to Aid in Medical Treatment, Say Nano Med Tech …
A process to mold multifaceted shapes into nanoparticles has been discovered by a team of researchers at Shanghai’s Nano Med Tech. The modified chemical process hollows particles into shapes including three dimensional boxes and honeycomb-like multi-chambered shapes. The researchers were confident that this process can be refined to create increasingly complex shapes which could revolutionize medical diagnosis and treatment.
"We are already able to control the process to the extent that…
Nano Med Tech Announces Launch of New Website
Nano Med Tech, which has rapidly expanded its operations in the wake of recent progress in the area of malignant cell targeting, is pleased to announce the launch of its new website. The organization, which is on the cutting edge of nano-technology research and application, has officially launched its redesigned and updated website.
“While it took awhile to get a product we were ultimately happy with, we couldn’t be…
